J Cell Biol. 2021 Dec 06;220(12). doi: 10.1083/jcb.202104114. Epub 2021 Nov 15.
Microtubule-associated proteins promote microtubule generation in the absence of γ-tubulin in human colon cancer cells.
The Journal of cell biology
Kenta Tsuchiya, Gohta Goshima
Affiliations
Affiliations
- Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
- Sugashima Marine Biological Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.
PMID: 34779859
PMCID: PMC8598081 DOI: 10.1083/jcb.202104114
Abstract
The γ-tubulin complex acts as the predominant microtubule (MT) nucleator that initiates MT formation and is therefore an essential factor for cell proliferation. Nonetheless, cellular MTs are formed after experimental depletion of the γ-tubulin complex, suggesting that cells possess other factors that drive MT nucleation. Here, by combining gene knockout, auxin-inducible degron, RNA interference, MT depolymerization/regrowth assay, and live microscopy, we identified four microtubule-associated proteins (MAPs), ch-TOG, CLASP1, CAMSAPs, and TPX2, which are involved in γ-tubulin-independent MT generation in human colon cancer cells. In the mitotic MT regrowth assay, nucleated MTs organized noncentriolar MT organizing centers (ncMTOCs) in the absence of γ-tubulin. Depletion of CLASP1 or TPX2 substantially delayed ncMTOC formation, suggesting that these proteins might promote MT nucleation in the absence of γ-tubulin. In contrast, depletion of ch-TOG or CAMSAPs did not affect the timing of ncMTOC appearance. CLASP1 also accelerates γ-tubulin-independent MT regrowth during interphase. Thus, MT generation can be promoted by MAPs without the γ-tubulin template.
© 2021 Tsuchiya and Goshima.
References
- Nat Cell Biol. 2012 Feb 05;14(3):295-303 - PubMed
- J Cell Biol. 2021 Mar 1;220(3): - PubMed
- Nat Rev Mol Cell Biol. 2012 Dec;13(12):789-803 - PubMed
- Curr Opin Cell Biol. 2021 Feb;68:124-131 - PubMed
- Cell Struct Funct. 2018 Mar 28;43(1):53-60 - PubMed
- J Cell Biol. 2005 Aug 15;170(4):571-82 - PubMed
- Cancer Res. 1981 May;41(5):1751-6 - PubMed
- Science. 2015 Jun 5;348(6239):1155-60 - PubMed
- Nat Methods. 2014 Jul;11(7):731-3 - PubMed
- Clin Cancer Res. 2011 Dec 15;17(24):7614-24 - PubMed
- Dev Cell. 2020 Jun 8;53(5):603-617.e8 - PubMed
- Dev Cell. 2017 Feb 27;40(4):405-420.e2 - PubMed
- Dev Cell. 2006 Apr;10(4):509-20 - PubMed
- Curr Biol. 2021 Jan 11;31(1):115-127.e3 - PubMed
- EMBO J. 2009 Apr 22;28(8):1016-28 - PubMed
- Exp Cell Res. 2009 Apr 15;315(7):1085-99 - PubMed
- J Cell Biol. 2008 May 5;181(3):421-9 - PubMed
- J Cell Biol. 2021 Apr 5;220(4): - PubMed
- Dev Cell. 2016 Oct 10;39(1):44-60 - PubMed
- Nat Cell Biol. 2015 Nov;17(11):1422-34 - PubMed
- Dev Cell. 2014 Feb 10;28(3):295-309 - PubMed
- Cell. 2010 Oct 15;143(2):263-74 - PubMed
- Dev Cell. 2010 Aug 17;19(2):245-58 - PubMed
- Dev Cell. 2007 Jun;12(6):917-30 - PubMed
- J Cell Biol. 2002 Oct 28;159(2):255-66 - PubMed
- Mol Biol Cell. 2020 Sep 15;31(20):2187-2194 - PubMed
- Nature. 2020 Feb;578(7795):467-471 - PubMed
- J Biol Chem. 2010 Jul 16;285(29):22658-65 - PubMed
- Cell. 2020 Jan 9;180(1):165-175.e16 - PubMed
- Nat Cell Biol. 2020 Mar;22(3):297-309 - PubMed
- Mol Biol Cell. 2010 Nov 15;21(22):3963-72 - PubMed
- Cell. 2008 Jan 11;132(1):79-88 - PubMed
- J Cell Biol. 2019 Jul 1;218(7):2150-2168 - PubMed
- Nat Cell Biol. 2015 Jul;17(7):907-16 - PubMed
- Nat Commun. 2020 Jan 14;11(1):270 - PubMed
- Mol Cell. 2007 Sep 21;27(6):976-91 - PubMed
- Biomolecules. 2019 Jan 15;9(1): - PubMed
- Mol Biol Cell. 2009 Mar;20(5):1348-59 - PubMed
- Elife. 2020 Jan 14;9: - PubMed
- Elife. 2015 Sep 15;4:e08649 - PubMed
- J Cell Biol. 2016 Nov 7;215(3):357-368 - PubMed
- J Cell Biol. 2015 Dec 7;211(5):999-1009 - PubMed
- Elife. 2018 May 31;7: - PubMed
- Mol Biol Cell. 2008 Jul;19(7):3163-78 - PubMed
- Oncotarget. 2016 Aug 2;7(31):50290-50301 - PubMed
- FEBS Lett. 2017 Aug;591(16):2379-2393 - PubMed
- Curr Biol. 2009 Sep 29;19(18):1566-72 - PubMed
- Curr Biol. 2016 Jul 11;26(13):1728-1736 - PubMed
- Nat Rev Mol Cell Biol. 2017 Nov;18(11):702-710 - PubMed
- J Cell Sci. 2017 Nov 1;130(21):3676-3684 - PubMed
- Elife. 2020 Jan 14;9: - PubMed
- Nat Cell Biol. 2006 Feb;8(2):137-47 - PubMed
- Mol Biol Cell. 2004 Apr;15(4):1580-90 - PubMed
- Biochem Pharmacol. 2010 Jan 15;79(2):122-9 - PubMed
- Nature. 1995 Dec 7;378(6557):578-83 - PubMed
- Nature. 1989 Apr 20;338(6217):662-4 - PubMed
- J Cell Biol. 2008 Jul 28;182(2):289-300 - PubMed
- J Biol Chem. 1999 Jun 11;274(24):17267-74 - PubMed
- Cell. 2017 Jun 1;169(6):1066-1077.e10 - PubMed
- J Cell Biol. 2002 May 13;157(4):591-602 - PubMed
- Oncogene. 2014 Jul 3;33(27):3550-60 - PubMed
- Nat Commun. 2015 Oct 27;6:8722 - PubMed
- J Cell Biol. 2005 Jan 3;168(1):141-53 - PubMed
- J Cell Biol. 2013 Jul 8;202(1):25-33 - PubMed
- J Cell Biol. 2010 Dec 13;191(6):1089-95 - PubMed
- Cell. 2008 Nov 28;135(5):948-59 - PubMed
- Front Pharmacol. 2015 Jun 16;6:120 - PubMed
- Mol Biol Cell. 2004 Dec;15(12):5318-28 - PubMed
- Neuron. 2014 Jun 4;82(5):1058-73 - PubMed
- Cell Cycle. 2008 Sep 1;7(17):2691-704 - PubMed
- Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20029-34 - PubMed
- Cell Rep. 2016 Apr 5;15(1):210-218 - PubMed
- J Phys Condens Matter. 2011 Sep 21;23(37):374104 - PubMed
- Cytoskeleton (Hoboken). 2011 May;68(5):266-78 - PubMed
- Curr Biol. 2018 Jun 4;28(11):1681-1691.e4 - PubMed
- PLoS Biol. 2018 Aug 6;16(8):e2005189 - PubMed
- Nat Cell Biol. 2018 May;20(5):575-585 - PubMed
- Mol Biol Cell. 2016 Oct 1;27(19):2935-45 - PubMed
- Mol Biol Cell. 2008 Jan;19(1):115-25 - PubMed
- Nat Cell Biol. 2002 Nov;4(11):871-9 - PubMed
- Curr Biol. 2006 Mar 7;16(5):536-41 - PubMed
- Essays Biochem. 2018 Dec 7;62(6):765-780 - PubMed
- EMBO Rep. 2018 Nov;19(11): - PubMed
- PLoS Biol. 2010 Apr 06;8(4):e1000350 - PubMed
- Dev Cell. 2018 Jul 2;46(1):40-58.e8 - PubMed
- Plant Cell. 2015 Jan;27(1):228-42 - PubMed
- J Cell Biol. 2003 Nov 10;163(3):451-6 - PubMed
Publication Types